Frank I Lin, M.D.

National Cancer Institute (NCI)

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

1 more share only the name and are not shown

Trial papers in glioma

PubMed author-name match

Trials

Studies that name Frank I Lin, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:17 UTC. Open this list on ClinicalTrials.gov

Ph1
NCT06479811 · [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
National Cancer Institute (NCI) · recruiting · Sinonasal Neuroendocrine Carcinoma, Nasopharyngeal Carcinoma, Esthesioneuroblastoma · principal investigator
Ph1/Ph2
NCT06427798 · Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
National Cancer Institute (NCI) · recruiting · Somatostatin Receptor Positive, Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma · principal investigator
Ph1/Ph2
NCT04086485 · Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
National Cancer Institute (NCI) · recruiting · Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Neoplasms · principal investigator
Ph2
NCT03206060 · Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Cancer Institute (NCI) · recruiting · Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in glioma.